The role of CYP26 enzymes in retinoic acid clearance

Bibliography

• Tzimas G, Nau H. The role of metabolism and toxicokinetics in retinoid teratogenesis. Curr Pharm Des 2001;7:803-31
   PubMed Web of Science ®Google Scholar
• Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol 2006;66:606-30
   PubMedGoogle Scholar
• Kane MA, Folias AE, Wang C, et al. Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandem mass spectrometry. Anal Chem 2008;80:1702-8
   PubMed Web of Science ®Google Scholar
• Tang GW, Russell RM. 13-cis-retinoic acid is an endogenous compound in human serum. J Lipid Res 1990;31:175-82
   PubMed Web of Science ®Google Scholar
• Tzimas G, Collins MD, Burgin H, et al. Embryotoxic doses of vitamin A to rabbits result in low plasma but high embryonic concentrations of all-trans-retinoic acid: risk of vitamin A exposure in humans. J Nutr 1996;126:2159-71
   PubMed Web of Science ®Google Scholar
• Napoli JL. Retinoid binding-proteins redirect retinoid metabolism: biosynthesis and metabolism of retinoic acid. Semin Cell Dev Biol 1997;8:403-15
   PubMed Web of Science ®Google Scholar
• Ross AC. Cellular metabolism and activation of retinoids: roles of cellular retinoid-binding proteins. Faseb J 1993;7:317-27
   PubMed Web of Science ®Google Scholar
• Eckhoff C, Collins MD, Nau H. Human plasma all-trans-, 13-cis- and 13-cis-4-oxoretinoic acid profiles during subchronic vitamin A supplementation: comparison to retinol and retinyl ester plasma levels. J Nutr 1991;121:1016-25
   PubMed Web of Science ®Google Scholar
• Fex G, Felding P. Factors affecting the concentration of free holo retinol-binding protein in human plasma. Eur J Clin Invest 1984;14:146-9
   PubMed Web of Science ®Google Scholar
• Eckhoff C, Nau H. Identification and quantitation of all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma. J Lipid Res 1990;31:1445-54
   PubMed Web of Science ®Google Scholar
• Kane MA, Chen N, Sparks S, et al. Quantification of endogenous retinoic acid in limited biological samples by LC/MS/MS. Biochem J 2005;388:363-9
   PubMed Web of Science ®Google Scholar
• Chen H, Namkung MJ, Juchau MR. Biotransformation of all-trans-retinol and all-trans-retinal to all-trans-retinoic acid in rat conceptal homogenates. Biochem Pharmacol 1995;50:1257-64
   PubMed Web of Science ®Google Scholar
• Chen H, Howald WN, Juchau MR. Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes. Drug Metab Dispos 2000;28:315-22
   PubMed Web of Science ®Google Scholar
• Zhang QY, Dunbar D, Kaminsky L. Human cytochrome P-450 metabolism of retinals to retinoic acids. Drug Metab Dispos 2000;28:292-7
   PubMed Web of Science ®Google Scholar
• Marill J, Idres N, Capron CC, et al. Retinoic acid metabolism and mechanism of action: a review. Curr Drug Metab 2003;4:1-10
   PubMed Web of Science ®Google Scholar
• Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med 1995;333:1369-73
   PubMed Web of Science ®Google Scholar
• Melhus H, Michaelsson K, Kindmark A, et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med 1998;129:770-8
   PubMed Web of Science ®Google Scholar
• Ross AC. Vitamin A status: relationship to immunity and the antibody response. Proc Soc Exp Biol Med 1992;200:303-20
   PubMed Web of Science ®Google Scholar
• World_Health_Organization. Macronutrient deficiencies: vitamin A deficiency. [cited 4 April 2009]; Available from: http://www.who.int/nutrition/topics/vad/en/index.html
   Google Scholar
• Jacobs S, Lie DC, Decicco KL, et al. Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proc Natl Acad Sci U S A 2006;103:3902-7
   PubMed Web of Science ®Google Scholar
• Goodman AB. Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset alzheimer disease. J Cell Physiol 2006;209:598-603
   PubMed Web of Science ®Google Scholar
• Ding Y, Qiao A, Wang Z, et al. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci 2008;28:11622-34
   PubMed Web of Science ®Google Scholar
• Girard C, Dereure O, Blatiere V, et al. Vitamin a deficiency phrynoderma associated with chronic giardiasis. Pediatr Dermatol 2006;23:346-9
   PubMed Web of Science ®Google Scholar
• Petkovich M, Brand NJ, Krust A, et al. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987;330:444-50
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995;83:841-50
   PubMed Web of Science ®Google Scholar
• Schug TT, Berry DC, Shaw NS, et al. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 2007;129:723-33
   PubMed Web of Science ®Google Scholar
• Nowickyj SM, Chithalen JV, Cameron D, et al. Locust retinoid X receptors: 9-Cis-retinoic acid in embryos from a primitive insect. Proc Natl Acad Sci USA 2008;105:9540-5
   PubMed Web of Science ®Google Scholar
• Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell 2008;134:921-31
   PubMed Web of Science ®Google Scholar
• Napoli JL. Retinoic acid biosynthesis and metabolism. Faseb J 1996;10:993-1001
   PubMed Web of Science ®Google Scholar
• Budhu AS, Noy N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol Cell Biol 2002;22:2632-41
   PubMed Web of Science ®Google Scholar
• Fiorella PD, Napoli JL. Expression of cellular retinoic acid binding protein (CRABP) in Escherichia coli. Characterization and evidence that holo-CRABP is a substrate in retinoic acid metabolism. J Biol Chem 1991;266:16572-9
   PubMed Web of Science ®Google Scholar
• Fiorella PD, Napoli JL. Microsomal retinoic acid metabolism. Effects of cellular retinoic acid-binding protein (type I) and C18-hydroxylation as an initial step. J Biol Chem 1994;269:10538-44
   PubMed Web of Science ®Google Scholar
• White JA, Boffa MB, Jones B, et al. A zebrafish retinoic acid receptor expressed in the regenerating caudal fin. Development 1994;120:1861-72
   PubMed Web of Science ®Google Scholar
• White JA, Guo YD, Baetz K, et al. Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. J Biol Chem 1996;271:29922-7
   PubMed Web of Science ®Google Scholar
• Ray WJ, Bain G, Yao M, et al. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J Biol Chem 1997;272:18702-8
   PubMed Web of Science ®Google Scholar
• White JA, Beckett-jones B, Guo YD, et al. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J Biol Chem 1997;272:18538-41
   PubMed Web of Science ®Google Scholar
• Fujii H, Sato T, Kaneko S, et al. Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos. Embo J 1997;16:4163-73
   PubMed Web of Science ®Google Scholar
• Wang Y, Zolfaghari R, Ross AC. Cloning of rat cytochrome P450RAI (CYP26) cDNA and regulation of its gene expression by all-trans-retinoic acid in vivo. Arch Biochem Biophys 2002;401:235-43
   PubMed Web of Science ®Google Scholar
• Swindell EC, Thaller C, Sockanathan S, et al. Complementary domains of retinoic acid production and degradation in the early chick embryo. Dev Biol 1999;216:282-96
   PubMed Web of Science ®Google Scholar
• Kruger KA, Blum JW, Greger DL. Expression of nuclear receptor and target genes in liver and intestine of neonatal calves fed colostrum and vitamin A. J Dairy Sci 2005;88:3971-81
   PubMed Web of Science ®Google Scholar
• Taimi M, Helvig C, Wisniewski J, et al. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J Biol Chem 2004;279:77-85
   PubMed Web of Science ®Google Scholar
• White JA, Ramshaw H, Taimi M, et al. Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proc Natl Acad Sci USA 2000;97:6403-8
   PubMed Web of Science ®Google Scholar
• Hernandez RE, Putzke AP, Myers JP, et al. Cyp26 enzymes generate the retinoic acid response pattern necessary for hindbrain development. Development 2007;134:177-87
   PubMed Web of Science ®Google Scholar
• Maclean G, Abu-abed S, Dolle P, et al. Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis with Cyp26A1 during early murine development. Mech Dev 2001;107:195-201
   PubMed Web of Science ®Google Scholar
• Tahayato A, Dolle P, Petkovich M. Cyp26C1 encodes a novel retinoic acid-metabolizing enzyme expressed in the hindbrain, inner ear, first branchial arch and tooth buds during murine development. Gene Expr Patterns 2003;3:449-54
   PubMed Web of Science ®Google Scholar
• Zhao Q, Dobbs-mcauliffe B, Linney E. Expression of cyp26b1 during zebrafish early development. Gene Expr Patterns 2005;5:363-9
   PubMed Web of Science ®Google Scholar
• Gu X, Xu F, Song W, et al. A novel cytochrome P450, zebrafish Cyp26D1, is involved in metabolism of all-trans retinoic acid. Mol Endocrinol 2006;20:1661-72
   PubMed Web of Science ®Google Scholar
• Gu X, Xu F, Wang X, et al. Molecular cloning and expression of a novel CYP26 gene (cyp26d1) during zebrafish early development. Gene Expr Patterns 2005;5:733-9
   PubMed Web of Science ®Google Scholar
• Nelson DR, Koymans L, Kamataki T, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996;6:1-42
   PubMedGoogle Scholar
• Uehara M, Yashiro K, Mamiya S, et al. CYP26A1 and CYP26C1 cooperatively regulate anterior-posterior patterning of the developing brain and the production of migratory cranial neural crest cells in the mouse. Dev Biol 2007;302:399-411
   PubMed Web of Science ®Google Scholar
• Gomaa MS, Yee SW, Milbourne CE, et al. Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand binding. J Enzyme Inhib Med Chem 2006;21:361-9
   PubMed Web of Science ®Google Scholar
• Abu-Abed S, Dolle P, Metzger D, et al. The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev 2001;15:226-40
   PubMed Web of Science ®Google Scholar
• Niederreither K, Abu-Abed S, Schuhbaur B, et al. Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development. Nat Genet 2002;31:84-8
   PubMed Web of Science ®Google Scholar
• Yashiro K, Zhao X, Uehara M, et al. Regulation of retinoic acid distribution is required for proximodistal patterning and outgrowth of the developing mouse limb. Dev Cell 2004;6:411-22
   PubMed Web of Science ®Google Scholar
• Abu-Abed S, MacLean G, Fraulob V, et al. Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis. Mech Dev 2002;110:173-7
   PubMed Web of Science ®Google Scholar
• Sakai Y, Meno C, Fujii H, et al. The retinoic acid-inactivating enzyme CYP26 is essential for establishing an uneven distribution of retinoic acid along the anterio-posterior axis within the mouse embryo. Genes Dev 2001;15:213-25
   PubMed Web of Science ®Google Scholar
• Xi J, Yang Z. Expression of RALDHs (ALDH1As) and CYP26s in human tissues and during the neural differentiation of P19 embryonal carcinoma stem cell. Gene Expr Patterns 2008;8:438-42
   PubMed Web of Science ®Google Scholar
• Trofimova-Griffin ME, Brzezinski MR, Juchau MR. Patterns of CYP26 expression in human prenatal cephalic and hepatic tissues indicate an important role during early brain development. Brain Res Dev Brain Res 2000;120:7-16
   PubMedGoogle Scholar
• Loudig O, Babichuk C, White J, et al. Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism. Mol Endocrinol 2000;14:1483-97
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Zolfaghari R, Ross AC. Regulation of CYP26 (cytochrome P450RAI) mRNA expression and retinoic acid metabolism by retinoids and dietary vitamin A in liver of mice and rats. Faseb J 2000;14:2119-27
   PubMed Web of Science ®Google Scholar
• Lampen A, Meyer S, Nau H. Effects of receptor-selective retinoids on CYP26 gene expression and metabolism of all-trans-retinoic acid in intestinal cells. Drug Metab Dispos 2001;29:742-7
   PubMed Web of Science ®Google Scholar
• Ozpolat B, Mehta K, Lopez-Berestein G. Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells. Leuk Lymphoma 2005;46:1497-506
   PubMed Web of Science ®Google Scholar
• Chithalen JV, Luu L, Petkovich M, et al. HPLC-MS/MS analysis of the products generated from all-trans-retinoic acid using recombinant human CYP26A. J Lipid Res 2002;43:1133-42
   PubMed Web of Science ®Google Scholar
• Frolik CA, Roberts AB, Tavela TE, et al. Isolation and identification of 4-hydroxy- and 4-oxoretinoic acid. In vitro metabolites of all-trans-retinoic acid in hamster trachea and liver. Biochemistry 1979;18:2092-7
   PubMed Web of Science ®Google Scholar
• John KV, Lakshmanan MR, Cama HR. Preparation, properties and metabolism of 5,6-monoepoxyretinoic acid. Biochem J 1967;103:539-43
   PubMed Web of Science ®Google Scholar
• Mccormick AM, Napoli JL, Schnoes HK, et al. Isolation and identification of 5, 6-epoxyretinoic acid: a biologically active metabolite of retinoic acid. Biochemistry 1978;17:4085-90
   PubMed Web of Science ®Google Scholar
• Pijnappel WW, Hendriks HF, Folkers GE, et al. The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification. Nature 1993;366:340-4
   PubMed Web of Science ®Google Scholar
• Samokyszyn VM, Gall WE, Zawada G, et al. 4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7. J Biol Chem 2000;275:6908-14
   PubMed Web of Science ®Google Scholar
• Chen H, Fantel AG, Juchau MR. Catalysis of the 4-hydroxylation of retinoic acids by cyp3a7 in human fetal hepatic tissues. Drug Metab Dispos 2000;28:1051-7
   PubMed Web of Science ®Google Scholar
• Marill J, Cresteil T, Lanotte M, et al. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol 2000;58:1341-8
   PubMed Web of Science ®Google Scholar
• Mcsorley LC, Daly AK. Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation. Biochem Pharmacol 2000;60:517-26
   PubMed Web of Science ®Google Scholar
• Nadin L, Murray M. Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes. Biochem Pharmacol 1999;58:1201-8
   PubMed Web of Science ®Google Scholar
• Package insert for Vesanoid (R) (tretinoin capsules): Roche Pharmaceuticals, Roche Laboratories Inc.; 2000
   Google Scholar
• Cullum ME, Zile MH. Metabolism of all-trans-retinoic acid and all-trans-retinyl acetate. Demonstration of common physiological metabolites in rat small intestinal mucosa and circulation. J Biol Chem 1985;260:10590-6
   PubMed Web of Science ®Google Scholar
• Marill J, Capron CC, Idres N, et al. Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids. Biochem Pharmacol 2002;63:933-43
   PubMed Web of Science ®Google Scholar
• Lee SJ, Perera L, Coulter SJ, et al. The discovery of new coding alleles of human CYP26A1 that are potentially defective in the metabolism of all-trans retinoic acid and their assessment in a recombinant cDNA expression system. Pharmacogenet Genomics 2007;17:169-80
   PubMed Web of Science ®Google Scholar
• Lutz JD, Dixit V, Yeung CK, et al. Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase. Biochem Pharmacol 2009;77:258-68
   PubMed Web of Science ®Google Scholar
• Rostami-Hodjegan A, Tucker GT. Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nat Rev Drug Discov 2007;6:140-8
   PubMed Web of Science ®Google Scholar
• Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988;72:567-72
   PubMed Web of Science ®Google Scholar
• Jones H, Blanc D, Cunliffe WJ. 13-cis retinoic acid and acne. Lancet 1980;2:1048-9
   PubMed Web of Science ®Google Scholar
• Altucci L, Leibowitz MD, Ogilvie KM, et al. RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov 2007;6:793-810
   PubMed Web of Science ®Google Scholar
• Center for drug evaluation and research, approval package for application number NDA20-438/S-001, final printed labeling for Accutane (R) (isotretinoin capsules) Roche Pharmaceuticals, Roche Laboratories Inc.; 2007
   Google Scholar
• Ozpolat B, Lopez-Berestein G, Adamson P, et al. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers. J Pharm Pharm Sci 2003;6:292-301
   PubMed Web of Science ®Google Scholar
• Muindi JR, Frankel SR, Huselton C, et al. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 1992;52:2138-42
   PubMed Web of Science ®Google Scholar
• Lazzarino M, Regazzi MB, Corso A. Clinical relevance of all-trans retinoic acid pharmacokinetics and its modulation in acute promyelocytic leukemia. Leuk Lymphoma 1996;23:539-43
   PubMed Web of Science ®Google Scholar
• Sun SY, Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 2002;41:41-55
   PubMed Web of Science ®Google Scholar
• Schwartz EL, Hallam S, Gallagher RE, et al. Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. Biochem Pharmacol 1995;50:923-8
   PubMed Web of Science ®Google Scholar
• Vanier KL, Mattiussi AJ, Johnston DL. Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemia. J Pediatr Hematol Oncol 2003;25:403-4
   PubMed Web of Science ®Google Scholar
• Rigas JR, Francis PA, Muindi JR, et al. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole. J Natl Cancer Inst 1993;85:1921-6
   PubMed Web of Science ®Google Scholar
• Njar VC. Cytochrome p450 retinoic acid 4-hydroxylase inhibitors: potential agents for cancer therapy. Mini Rev Med Chem 2002;2:261-9
   PubMed Web of Science ®Google Scholar
• Njar VC, Gediya L, Purushottamachar P, et al. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg Med Chem 2006;14:4323-40
   PubMed Web of Science ®Google Scholar
• Patel JB, Huynh CK, Handratta VD, et al. Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice. J Med Chem 2004;47:6716-29
   PubMed Web of Science ®Google Scholar
• Miller VA, Rigas JR, Muindi JR, et al. Modulation of all-trans retinoic acid pharmacokinetics by liarozole. Cancer Chemother Pharmacol 1994;34:522-6
   PubMed Web of Science ®Google Scholar
• Stoppie P, Borgers M, Borghgraef P, et al. R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents. J Pharmacol Exp Ther 2000;293:304-12
   PubMed Web of Science ®Google Scholar
• Mulvihill MJ, Kan JL, Beck P, et al. Potent and selective [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-ami nes as retinoic acid metabolic blocking agents (RAMBAs). Bioorg Med Chem Lett 2005;15:1669-73
   PubMed Web of Science ®Google Scholar
• Mulvihill MJ, Kan JL, Cooke A, et al. 3-[6-(2-Dimethylamino-1-imidazol-1-yl-butyl)-naphthalen-2-yloxy]-2,2-dimet hyl-propionic acid as a highly potent and selective retinoic acid metabolic blocking agent. Bioorg Med Chem Lett 2006;16:2729-33
   PubMed Web of Science ®Google Scholar
• Yee SW, Jarno L, Gomaa MS, et al. Novel tetralone-derived retinoic acid metabolism blocking agents: synthesis and in vitro evaluation with liver microsomal and MCF-7 CYP26A1 cell assays. J Med Chem 2005;48:7123-31
   PubMed Web of Science ®Google Scholar
• Van Heusden J, Van Ginckel R, Bruwiere H, et al. Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity. Br J Cancer 2002;86:605-11
   PubMed Web of Science ®Google Scholar
• Fex G, Larsson K, Andersson A, et al. Low serum concentration of all-trans and 13-cis retinoic acids in patients treated with phenytoin, carbamazepine and valproate. Possible relation to teratogenicity. Arch Toxicol 1995;69:572-4
   PubMed Web of Science ®Google Scholar
• Nau H, Tzimas G, Mondry M, et al. Antiepileptic drugs alter endogenous retinoid concentrations: a possible mechanism of teratogenesis of anticonvulsant therapy. Life Sci 1995;57:53-60
   PubMed Web of Science ®Google Scholar